Photo by AlbyDeTweede/iStock via Getty Images
Enveric Biosciences (ENVB) is a pre-clinical and clinical stage pharmaceutical company which focuses on the treatment of the side-effects of cancer and the treatment of tumorous growths using synthetic cannabinoids (CBD). I recently covered the stock and described their research pipeline. With their acquisition of MagicMed, the company has expanded its research agenda to new compounds and treatments. According to a Seeking Alpha article, on the news…

Click here to view the original article.